
Read more VitroScan Technology
Fast and accurate ex vivo 3D tumor testing to support better informed treatment decisions & improve patient stratification for clinical trials.
Read more
Read more Personalized Treatment
In VitroScan's ongoing clinical trial program predictive algorithms are established and validated for multiple drugs and cancer types.
Read more
Read more Patient Stratification
VitroScan is offering services to improve patient stratification for clinical trials by identification of the tumors that are responsive to (novel) therapies.
Read moreNews & Events

Read more VitroScans Chemo Sensitivity Score predicts response to carboplatin and paclitaxel for ovarian cancer patients
5 June 2023
First publication of the predictive value of our ex vivo tumor testing platform at ASCO23.
Read more
Read more VitroScan presents the classification of cancer patients into responders and non responders to immunotherapy at AACR23
18 April 2023
VitroScan presents the classification of cancer patients into responders and non responders to immunotherapy at AACR23.
Read more
Read more VitroScan and Imuno are awarded a MIT grant to develop a platform to de-risk clinical development of immunotherapy for bladder cancer patients!
27 January 2023
We are are proud to announce that VitroScan and Imuno have been awarded the MIT R&D-Samenwerkingsproject Trial Booster (€992.600) by the province Zuid-Holland!
Read more